Berlin

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• High blood pressure1 trial
• Obesity1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Alnylam Pharmaceuticals2 trials

Closed trials

• Completed

  Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

  NCT06272487· Phase 2· Alnylam Pharmaceuticals· Source

• Terminated

  A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

  NCT05761301· Phase 1/2· Alnylam Pharmaceuticals· Source